Hope
for Healing,
elecell.
With a foundation in biomimetic current technology, elecell is trailblazing next-generation regenerative medicine. Our mission is to conduct research that swiftly and practically enhances human lives, reshaping the healthcare landscape and offering hope and solutions where they are most needed.
Our Purpose.
We aim to heal and promote a healthier
future for those who have been wounded,
using innovative biological and medical
technology commercialization.
Core Values.
We are dedicated to researching and swiftly commercializing groundbreaking bio and medical technologies to improve human life. Our mission is to support individuals affected by injuries, illnesses, and chronic diseases, offering solutions for the best possible quality of life.
Trust.
By providing safe and effective solutions backed by scientific studies, we cultivate trust with our customers.
Impact.
Our mission is to provide cutting-edge solutions that improve health and elevate quality of life.
Sustainability.
In research, product development, and business operations, we uphold sustainable practices and environmental responsibility.
The world's first wound
treatment technology using
bio-similar current.
elecell's devices for tissue regeneration and wound healing, utilizing biomimetic currents, promise life-changing outcomes for individuals dealing with bodily damage, offering potentially life-saving solutions.
· Biomimetic current-based portable wound treatment device.
· Natural product-based recovery support.
· Electrical stimulation-based muscle cell therapy.
Core Technology.
Biomimetic current-based portable wound treatment device.
Our next-gen wound healing technology utilizes self-generated electrical stimulation. We've created a biomimetic current self-generation system that enhances cell regeneration to speed up wound healing. This innovative solution is non-invasive and portable, providing treatment for both minor and severe wounds without any side effects.
Natural product-based recovery support.
Our innovation is a natural anti-inflammatory topical treatment made from plant-derived compounds and enzymes. We found natural ingredients that effectively enhance inflammation relief during the body's healing process. Scientific research has demonstrated that these natural components are officially proven to be safer and more effective than traditional anti-inflammatory drugs.
Electrical stimulation-based muscle cell therapy.
Our biomimetic current stimulation system has led to the creation of an advanced muscle cell therapy technology. By mimicking the body's natural electrical impulses, this technology facilitates muscle regeneration and rehabilitation. It provides groundbreaking solutions for individuals recovering from injuries or aiming to enhance muscle function. We are committed to optimizing the technology's efficacy and safety through ongoing research and cooperation with medical experts.
Team.
elecell was established by Korea’s top research professionals in medical science, biomedical engineering, biotechnology, and life chemistry. We have devoted ourselves to developing revolutionary solutions for healing and health, leading to the birth of our vision to broaden the possibilities in healthcare and drive transformative changes.
Hyung-Seop Han (Ph.D)
Co-founder & Ceo
• Doctor of Medical Science, University of Oxford
• Master’s degree in biomedical engineering from University of Iowa
• Bachelor of Science in Biomedical Engineering, University of Iowa
• Certification in Histology and Technology from Indiana University
• Korea Institute of Science and Technology (KIST), Researcher (’13~’19)
• Korea Institute of Science and Technology (KIST), Senior Researcher (’23~)
• Korea Institute of Science and Technology (KIST), Principal Researcher (’19~’23)
Jimin Park (Ph.D)
Co-founder & Director
• PhD in Materials Science and Engineering from MIT
• Master’s degree in Materials Science and Engineering, Seoul National University
• Bachelor’s degree in Materials Science and Engineering, Seoul National University
• Korea Advanced Institute of Science and Technology (KAIST), Department of Biological and Chemical Engineering, Assistant Professor
• California Institute of Technology (Caltech), Department of Life and Biomedical Engineering, Postdoctoral Research Associate
• Korea Institute of Science and Technology (KIST), researcher
Seung-Hoon Um (Ph.D)
CSO
• Seoul National University/Ph.D. in Biomaterials Science
• Seoul National University/Master’s in Biomaterials Science
• KAIST, Department of Applied Chemical Engineering, Appointed Researcher
• Seoul National University College of Dentistry, Dental Research Center, Researcher
• Korea Institute of Science and Technology (KIST), Biomedical Convergence Division, Biomaterials Research Center, Postdoctoral researcher
• Laval University, Department of Biomedical Engineering, Postdoctoral researcher
• Saint-François d'Assise Hospital, Tissue Regeneration Medical Research Center, CHU, Researcher
Youngmin Seo (Ph.D)
COO
• PhD in School of Integrative Engineering, Chung-Ang University
• Adjunct Professor, School of Integrative Engineering, Chung-Ang University
• Subcommittee Member, Medical Device Approval and Review Communication Group, Ministry of Food and Drug Safety
• Korea Medical Device Safety Information Center Innovative Medical Devices
Expert Committee
• Former CEO of OID lnc.
• Korean Orthopedic Association Manrye Foundation Award
Future Medical Research Foundation Bio-Venture
Competition Grand Prize
Ji-Soo Jang (Ph.D)
Advisors
• PhD in Materials Science and Engineering, KAIST
• Postdoctoral Researcher, Department of Chemical and Environmental Engineering, Yale University
• Assistant Professor, Department of Nano Engineering, Sungkyunkwan University
• Former Senior Researcher at the Korea Institute of Science and Technology (KIST)
• Research on the development of an electrical stimulation-based platform
• Selected as one of the Top 100 Outstanding National R&D Achievements by the Ministry of Science and ICT
('18)
Seungjoo Lee (MD, Ph.D)
Advisors
• Seoul Asan Medical Center
• Professor of department of neurosurgery
• Clinical assessment of wound treatment products and medical devices.
• Honored with the Best Paper Prize in Vascular Research, The 62nd Annual Autumn Symposium of the Korean Neurosurgical Society. (’22)
Sun-Woong Kang (Ph.D)
Advisors
• Korea Institute of Toxicology (KIT)
• Center Director at the National Toxicology Policy Center
• Product certification consulting and device toxicity testing
• Selected as an Outstanding Researcher at the Korea Institute of Toxicology (KIT) for two consecutive years (’16~’17)
• Awarded 'Top 5 Research Performance' in the Applied Technology category (’16)
News.
April 21, 2025
The Chosun Ilbo (Science Chosun, Chosun Biz) featured elecell lnc. as a frontier technology innovator in the pharmaceutical and biotechnology sector
The Chosun Ilbo (Science Chosun, Chosun Biz) featured eleccell lnc. as a frontier technology innovator in the pharmaceutical and biotechnology sector
February 21, 2025
Successfully Holds Kick-off Meeting to Celebrate Deep Tech TIPS Fast-Track Selection
Successfully Holds Kick-off Meeting to Celebrate Deep Tech TIPS Fast-Track Selection
February 14, 2025
elecell’s Research on Reactive Oxygen Species Removal Technology for Wound Healing Published in a Leading International Biomaterials Journal (BioactiveMaterials, IF=18.0)
elecell lnc.'s Research on Reactive Oxygen Species Removal Technology for Wound Healing Published in a Leading International Biomaterials Journal (BioactiveMaterials, IF=18.0)
February 5, 2025
elecell lnc. awarded the top prize at the R&D Special Zone Deep Tech Scale-up IR Contest.
elecell lnc. awarded the top prize at the R&D Special Zone Deep Tech Scale-up IR Contest.
Bio and medical technology
solutions leading to a brighter and
healthier future , Please support
elecell's journey.
Backed by.
Let's talk .
Through this partnership, we can advance biomimetic current-based tissue regeneration and wound healing technologies and share groundbreaking solutions. Learn more about our partnership with Eleccell and join us as we strive to bring the world's first next-generation treatments to market.
Partnerships enable us to advance our biomimetic current-based tissue regeneration and wound healing technologies and distribute cutting-edge solutions. Discover more about partnering with elecell and join us in our mission to advance and deploy the world’s first next-generation therapies.
Let's talk.
Partnerships enable us to advance our biomimetic current-based tissue regeneration and wound healing technologies and distribute cutting-edge solutions. Discover more about partnering with elecell and join us in our mission to advance and deploy the world’s first next-generation therapies.